Brinker Capital Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,465
| Closed | -$688K | – | 1926 |
|
|
2024
Q4 | $688K | Buy |
10,465
+321
| +3% | +$21.1K | 0.01% | 1227 |
|
|
2024
Q3 | $716K | Sell |
10,144
-104
| -1% | -$7.34K | 0.01% | 1189 |
|
|
2024
Q2 | $680K | Sell |
10,248
-89
| -0.9% | -$5.9K | 0.01% | 1165 |
|
|
2024
Q1 | $702K | Sell |
10,337
-616
| -6% | -$41.8K | 0.01% | 1139 |
|
|
2023
Q4 | $702K | Sell |
10,953
-1,035
| -9% | -$66.3K | 0.01% | 1087 |
|
|
2023
Q3 | $707K | Sell |
11,988
-702
| -6% | -$41.4K | 0.01% | 1067 |
|
|
2023
Q2 | $758K | Buy |
12,690
+1,398
| +12% | +$83.5K | 0.01% | 1058 |
|
|
2023
Q1 | $660K | Buy |
+11,292
| New | +$660K | 0.01% | 1037 |
|
|
2014
Q2 | – | Sell |
-171,000
| Closed | -$7.22M | – | 390 |
|
|
2014
Q1 | $7.22M | Sell |
171,000
-40,500
| -19% | -$1.71M | 0.28% | 78 |
|
|
2013
Q4 | $8.33M | Sell |
211,500
-75,300
| -26% | -$2.96M | 0.32% | 73 |
|
|
2013
Q3 | $10.2M | Buy |
286,800
+3,600
| +1% | +$128K | 0.41% | 66 |
|
|
2013
Q2 | $9.41M | Buy |
+283,200
| New | +$9.41M | 0.4% | 69 |
|